Are these 2 high P/E stocks worth buying now?

Ramsay Health Care Limited (ASX:RHC) and iProperty Group Ltd (ASX:IPP) may look high priced, but does their forecast high growth justify it?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many thrifty investors shy away from high-flying stocks with equally lofty price-earnings ratios. When your goal is to buy stocks at a fair price, a price at 30, 40, even 50 times earnings doesn't leave you much of a margin of safety. You really need confidence in the company story to pick it up at such a premium.

But can they be worth it?

Yes, there are some stocks that do deliver over a number of years and shareholders gain greatly.

There are also many cases when they fall flat on their face, sending investors scrambling for the exits.

I have two stocks that may be considered high priced, but are they still worth picking up for further gains?

—  iProperty Group Ltd (ASX: IPP) operates property search websites covering a number of Asian countries like Malaysia, Hong Kong, Macau, Indonesia and Singapore. In financial year 2013, the company had just 0.9 cents earnings per share. Based on forward earnings, it's trading at a P/E of 106! The company's largest shareholder is REA Group Limited (ASX: REA), the operator of Australia's number one property search website realestate.com.au, with a 19.9% stake.

Earnings per share in financial year 2014 are forecast to be 2.7 cents, and financial year 2015 is projected to be 7.6 cents per share. That would be a great rise in earnings, but it's difficult to say how the share price will perform. REA Group also started out with very small earnings, but they quickly grew larger.  Is it worth it?

I really don't know at this early stage. After the company has a number of years showing steady, strong earnings growth, it may be recommended, but not just yet.

—  Ramsay Health Care Limited (ASX: RHC) is trading at 33 times earnings. For a private hospital operator, that might seem high, but the healthcare provider is expected to grow earnings an average annual 18.2% over the next two years. Combined with a 1.5% fully franked yield, the stock isn't a steal, but because Ramsay has a long track record of sustained earnings growth, it is a more credible grower into the future.

That could give an investor more confidence in its business and share price growth. Ramsay has strong management to guide the company through its overseas expansion in Europe and Asia. I think Ramsay Health Care could be worth the premium over the long term.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »